- Previous Close
14,686.15 - Open
14,625.30 - Bid 14,649.85 x --
- Ask 14,718.10 x --
- Day's Range
14,508.00 - 14,797.25 - 52 Week Range
14,409.80 - 17,747.85 - Volume
700 - Avg. Volume
317 - Market Cap (intraday)
476.33B - Beta (5Y Monthly) 0.22
- PE Ratio (TTM)
70.27 - EPS (TTM)
208.54 - Earnings Date Feb 11, 2025
- Forward Dividend & Yield 190.00 (1.29%)
- Ex-Dividend Date Nov 19, 2024
- 1y Target Est
16,399.50
Procter & Gamble Hygiene and Health Care Limited engages in the manufacture and sale of branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. It operates through Healthcare Products and Hygiene Products segments. The company provides health care products, including ointments and creams, cough drops, and tablets; and hygiene products, such as feminine hygiene and other skin care hygiene products, as well as feminine care pads. It also offers baby care products comprising nappies, pants, and baby wipes; grooming products; laundry products; hair care products; home care products; and oral care products. The company offers its products under the Vicks, Whisper, Pampers, Ariel, Tide, Gillette, Head & Shoulders, Herbal Essences, Pantene, Ambi Pur, Oral-B, Olay, and Old Spice brand names. It sells its products through mass merchandisers, as well as grocery, membership club, drug, department, and high frequency stores. The company was incorporated in 1964 and is based in Mumbai, India. Procter & Gamble Hygiene and Health Care Limited operates as a subsidiary of The Procter & Gamble Company.
in.pg.com439
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Recent News: PGHH.BO
View MorePerformance Overview: PGHH.BO
Trailing total returns as of 1/14/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PGHH.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PGHH.BO
View MoreValuation Measures
Market Cap
477.39B
Enterprise Value
471.68B
Trailing P/E
70.50
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
11.38
Price/Book (mrq)
61.52
Enterprise Value/Revenue
11.25
Enterprise Value/EBITDA
46.13
Financial Highlights
Profitability and Income Statement
Profit Margin
16.09%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
42.03B
Net Income Avi to Common (ttm)
6.76B
Diluted EPS (ttm)
208.54
Balance Sheet and Cash Flow
Total Cash (mrq)
5.88B
Total Debt/Equity (mrq)
0.40%
Levered Free Cash Flow (ttm)
--